VERTEX PHARMACEUTICALS INC / MA Cash Equivalents, at Carrying Value
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Cash Equivalents, at Carrying Value of $48.70 million as of 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Balance Sheet › Assets › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2013-11-07
- 2013-09-30: Cash Equivalents, at Carrying Value $48.70M.
- 2013-06-30: Cash Equivalents, at Carrying Value $56.50M.
- 2013-03-31: Cash Equivalents, at Carrying Value $60.10M.
- 2012-12-31: Cash Equivalents, at Carrying Value $68.70M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2013-09-30 | $48.70M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $56.50M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $60.10M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $68.70M 10-K · filed 2013-03-01 |
| 2012-09-30 | $72.70M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $53.30M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $57.60M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $49.00M 10-K · filed 2012-02-22 |
| 2011-09-30 | $49.50M 10-Q · filed 2011-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |